| 2HE Stock | | | EUR 98.50 0.50 0.51% |
President
Mr. Darcy G. Mott is Chief Financial Officer, Executive Vice President of the Company. Mr. Mott has served as our Executive Vice President and Chief Financial Officer since February 2007. From 1999 to 2004, Mr. Mott was Vice President, Treasurer and Chief Financial Officer at The Canopy Group, a technology investment company, where he was responsible for all finance operations and served on the board of directors of several portfolio companies, both public and private. Prior to joining The Canopy Group, Mr. Mott served for 12 years in various financial management positions at Novell, Inc., a networking software company. Prior to joining Novell, Inc., Mr. Mott worked as an accountant at Arthur Andersen Co., serving a variety of public and private audit clients since 2007.
| Age | 70 |
| Tenure | 17 years |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
Mott holds a B.S. in Accounting from Brigham Young University and is a Certified Public Accountant.
Healthequity Management Efficiency
Healthequity's management efficiency ratios could be used to measure how well Healthequity manages its routine affairs as well as how well it operates its assets and liabilities.
Healthequity has accumulated 922.08
M in total debt with debt to equity ratio
(D/E) of 7.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Healthequity has a current ratio of 15.29, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Healthequity until it has trouble settling it off, either with new capital or with free cash flow. So, Healthequity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Healthequity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Healthequity to invest in growth at high rates of return. When we think about Healthequity's use of debt, we should always consider it together with cash and equity.
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. HealthEquity operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1141 people. Healthequity (2HE) is traded on Frankfurt Exchange in Germany and employs 3,688 people.
Management Performance
Healthequity Leadership Team
Elected by the shareholders, the Healthequity's board of directors comprises two types of representatives: Healthequity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthequity. The board's role is to monitor Healthequity's management team and ensure that shareholders' interests are well served. Healthequity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthequity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Kessler, President CEO, Director | |
| Darcy Mott, CFO, Executive Vice President | |
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | |
| Brad Bennion, Sr Devel | |
| Tyson Murdock, Ex CFO | |
| Elimelech Rosner, Ex CTO | |
| Tia Padia, VP Marketing | |
| Richard Putnam, IR Contact Officer | |
| Steve Lindsay, Ex Management | |
| Larry Trittschuh, Executive Vice President Chief Security Officer | |
Healthequity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthequity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Healthequity Stock
When determining whether Healthequity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthequity's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Healthequity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more detail on how to invest in Healthequity Stock please use our
How to Invest in Healthequity guide.
You can also try the
Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthequity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.